Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial [Phase 2]
This Phase 2 clinical trial evaluates siltuximab to prevent severe immune-related adverse events during rechallenge with immune checkpoint i…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating the effect of itraconazole on the pharmacokinetics of HS-20093 in patients with advanced solid tumors.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating RGL-270 alone and in combination with Adebelimab for high-risk recurrence after radical treatmen…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating JAB-23E73 in adults with KRAS-altered advanced solid tumors; the study is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies [Phase 1]
A Phase 1 clinical trial update describes ABX-001, an experimental immunotherapy, given alone and in combination with pembrolizumab for adva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometria…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-escalation and expansion trial of a SAR444200-based regimen in adults with advanced solid tumors; the study status is termina…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors [Phase 1]
Phase 1 safety and pharmacokinetics study of NM6603 in Chinese patients with advanced solid tumors is being conducted and is currently recru…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors [Phase 1, Phase 2]
A Phase I/II study of WJ22096 Tablets in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Adoption of Audio Recording in the Outpatient Supportive Care Center
This clinical trial update describes the adoption of audio recording in an outpatient supportive care center for patients with solid tumors …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update reports the first-in-human Phase 1 study of JAB-8263 in adults with advanced solid tumors, which has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports termination and posted results for a Phase 1/2 study of rintatolimod plus interferon alpha-2b in cancer p…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Phase I Comparative Bioavailability Study [Phase 1]
Clinical trial update describes a Phase I comparative bioavailability study sponsored by AstraZeneca for solid tumors that is currently acti…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial [Phase 3]
Phase 3 clinical trial evaluating geriatric evaluation and survivorship health education for older cancer survivors (GEM-S) is currently rec…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
This clinical trial update describes a study by the University of Minnesota evaluating methods for early identification of cognitive side ef…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors [Phase 1, Phase 2]
This update reports the completion of a Phase I/II clinical trial evaluating XNW5004 tablets in patients with relapsed/refractory advanced s…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) [Phase 1, Phase 2]
First-in-human study of Visugromab (CTL-002), a GDF-15 neutralizing antibody, in adults with advanced solid tumors (Phase 1/2). The trial st…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]
This update covers the Phase 1/2 study of the investigational agent NUC-7738 in patients with advanced solid tumors and lymphoma, focusing o…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of ABBV-927 and ABBV-181 in participants with advanced solid tumors is active but not currently recruiting, with ongoing immun…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The document reports a Phase 1/2 clinical trial of SHR-4610 injection in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial is evaluating cordycepin for treating CD8+ lymphocytopenia in patients with solid tumors and is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of MRX-2843 in adults with relapsed/refractory advanced and/or metastatic solid tumors; …
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors [Phase 1, Phase 2]
A dose-escalation study of APG-1387 in combination with toripalimab in advanced solid tumors has been terminated after Phase 1/Phase 2 evalu…